244 related articles for article (PubMed ID: 27081703)
1. MARCKS contributes to stromal cancer-associated fibroblast activation and facilitates ovarian cancer metastasis.
Yang Z; Xu S; Jin P; Yang X; Li X; Wan D; Zhang T; Long S; Wei X; Chen G; Meng L; Liu D; Fang Y; Chen P; Ma D; Gao Q
Oncotarget; 2016 Jun; 7(25):37649-37663. PubMed ID: 27081703
[TBL] [Abstract][Full Text] [Related]
2. Stromal Expression of MARCKS Protein in Ovarian Carcinomas Has Unfavorable Prognostic Value.
Doghri R; Manai M; Finetti P; Driss M; Agavnian E; Lopez M; Elghardallou M; Charafe-Jauffret E; Manai M; Chaffanet M; Birnbaum D; Mrad K; Bertucci F
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29295532
[TBL] [Abstract][Full Text] [Related]
3. An integrated analysis identifies STAT4 as a key regulator of ovarian cancer metastasis.
Zhao L; Ji G; Le X; Luo Z; Wang C; Feng M; Xu L; Zhang Y; Lau WB; Lau B; Yang Y; Lei L; Yang H; Xuan Y; Chen Y; Deng X; Yi T; Yao S; Zhao X; Wei Y; Zhou S
Oncogene; 2017 Jun; 36(24):3384-3396. PubMed ID: 28114283
[TBL] [Abstract][Full Text] [Related]
4. Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associated fibroblasts.
Moatassim-Billah S; Duluc C; Samain R; Jean C; Perraud A; Decaup E; Cassant-Sourdy S; Bakri Y; Selves J; Schmid H; Martineau Y; Mathonnet M; Pyronnet S; Bousquet C
Oncotarget; 2016 Jul; 7(27):41584-41598. PubMed ID: 27177087
[TBL] [Abstract][Full Text] [Related]
5. Systematic Identification of Druggable Epithelial-Stromal Crosstalk Signaling Networks in Ovarian Cancer.
Yeung TL; Sheng J; Leung CS; Li F; Kim J; Ho SY; Matzuk MM; Lu KH; Wong STC; Mok SC
J Natl Cancer Inst; 2019 Mar; 111(3):272-282. PubMed ID: 29860390
[TBL] [Abstract][Full Text] [Related]
6. Functional prediction of long non-coding RNAs in ovarian cancer-associated fibroblasts indicate a potential role in metastasis.
Vafaee F; Colvin EK; Mok SC; Howell VM; Samimi G
Sci Rep; 2017 Sep; 7(1):10374. PubMed ID: 28871211
[TBL] [Abstract][Full Text] [Related]
7. Myristoylated alanine-rich C kinase substrate (MARCKS): a multirole signaling protein in cancers.
Fong LWR; Yang DC; Chen CH
Cancer Metastasis Rev; 2017 Dec; 36(4):737-747. PubMed ID: 29039083
[TBL] [Abstract][Full Text] [Related]
8. The β-arrestin1/endothelin axis bolsters ovarian fibroblast-dependent invadosome activity and cancer cell metastatic potential.
Del Rio D; Masi I; Caprara V; Ottavi F; Albertini Petroni G; Salvati E; Trisciuoglio D; Giannitelli SM; Bagnato A; Mauri E; Spadaro F; Rosanò L
Cell Death Dis; 2024 May; 15(5):358. PubMed ID: 38777849
[TBL] [Abstract][Full Text] [Related]
9. Long Noncoding RNA LINC00092 Acts in Cancer-Associated Fibroblasts to Drive Glycolysis and Progression of Ovarian Cancer.
Zhao L; Ji G; Le X; Wang C; Xu L; Feng M; Zhang Y; Yang H; Xuan Y; Yang Y; Lei L; Yang Q; Lau WB; Lau B; Chen Y; Deng X; Yao S; Yi T; Zhao X; Wei Y; Zhou S
Cancer Res; 2017 Mar; 77(6):1369-1382. PubMed ID: 28087599
[TBL] [Abstract][Full Text] [Related]
10. Ovarian cancer cell-derived lysophosphatidic acid induces glycolytic shift and cancer-associated fibroblast-phenotype in normal and peritumoral fibroblasts.
Radhakrishnan R; Ha JH; Jayaraman M; Liu J; Moxley KM; Isidoro C; Sood AK; Song YS; Dhanasekaran DN
Cancer Lett; 2019 Feb; 442():464-474. PubMed ID: 30503552
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of Upregulation of Myristoylated Alanine-Rich C-Kinase Substrate in Gastric Cancer.
Quan R; Ning Z; Wang Y; Yu W; Zhu H
Med Sci Monit; 2019 Jan; 25():279-287. PubMed ID: 30623893
[TBL] [Abstract][Full Text] [Related]
12. COL11A1 activates cancer-associated fibroblasts by modulating TGF-β3 through the NF-κB/IGFBP2 axis in ovarian cancer cells.
Wu YH; Huang YF; Chang TH; Chen CC; Wu PY; Huang SC; Chou CY
Oncogene; 2021 Jul; 40(26):4503-4519. PubMed ID: 34117361
[TBL] [Abstract][Full Text] [Related]
13. Tackling MARCKS-PIP3 circuit attenuates fibroblast activation and fibrosis progression.
Yang DC; Li JM; Xu J; Oldham J; Phan SH; Last JA; Wu R; Chen CH
FASEB J; 2019 Dec; 33(12):14354-14369. PubMed ID: 31661644
[TBL] [Abstract][Full Text] [Related]
14. Cancer-associated fibroblasts-derived FMO2 as a biomarker of macrophage infiltration and prognosis in epithelial ovarian cancer.
Yu S; Yang R; Xu T; Li X; Wu S; Zhang J
Gynecol Oncol; 2022 Nov; 167(2):342-353. PubMed ID: 36114029
[TBL] [Abstract][Full Text] [Related]
15. Reprogramming of stromal fibroblasts by SNAI2 contributes to tumor desmoplasia and ovarian cancer progression.
Yang Z; Yang X; Xu S; Jin P; Li X; Wei X; Liu D; Huang K; Long S; Wang Y; Sun C; Chen G; Hu J; Meng L; Ma D; Gao Q
Mol Cancer; 2017 Oct; 16(1):163. PubMed ID: 29041931
[TBL] [Abstract][Full Text] [Related]
16. Sphingosine kinase 1 is required for TGF-β mediated fibroblastto- myofibroblast differentiation in ovarian cancer.
Beach JA; Aspuria PJ; Cheon DJ; Lawrenson K; Agadjanian H; Walsh CS; Karlan BY; Orsulic S
Oncotarget; 2016 Jan; 7(4):4167-82. PubMed ID: 26716409
[TBL] [Abstract][Full Text] [Related]
17. A Zebrafish Model Discovers a Novel Mechanism of Stromal Fibroblast-Mediated Cancer Metastasis.
Liu C; Zhang Y; Lim S; Hosaka K; Yang Y; Pavlova T; Alkasalias T; Hartman J; Jensen L; Xing X; Wang X; Lu Y; Nie G; Cao Y
Clin Cancer Res; 2017 Aug; 23(16):4769-4779. PubMed ID: 28420724
[No Abstract] [Full Text] [Related]
18. Cancer-associated fibroblasts secrete FGF-1 to promote ovarian proliferation, migration, and invasion through the activation of FGF-1/FGFR4 signaling.
Sun Y; Fan X; Zhang Q; Shi X; Xu G; Zou C
Tumour Biol; 2017 Jul; 39(7):1010428317712592. PubMed ID: 28718374
[TBL] [Abstract][Full Text] [Related]
19. Senescent Carcinoma-Associated Fibroblasts Upregulate IL8 to Enhance Prometastatic Phenotypes.
Wang T; Notta F; Navab R; Joseph J; Ibrahimov E; Xu J; Zhu CQ; Borgida A; Gallinger S; Tsao MS
Mol Cancer Res; 2017 Jan; 15(1):3-14. PubMed ID: 27678171
[TBL] [Abstract][Full Text] [Related]
20. Ovarian stromal cells as a source of cancer-associated fibroblasts in human epithelial ovarian cancer: A histopathological study.
Fujisawa M; Moh-Moh-Aung A; Zeng Z; Yoshimura T; Wani Y; Matsukawa A
PLoS One; 2018; 13(10):e0205494. PubMed ID: 30304016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
